Literature DB >> 12923300

Genetic programs and responses of neural stem/progenitor cells during demyelination: potential insights into repair mechanisms in multiple sclerosis.

Jaime Imitola1, Evan Y Snyder, Samia J Khoury.   

Abstract

In recent years, it has become evident that the adult mammalian CNS contains a population of neural stem cells (NSCs) described as immature, undifferentiated, multipotent cells, that may be called upon for repair in neurodegenerative and demyelinating diseases. NSCs may give rise to oligodendrocyte progenitor cells (OPCs) and other myelinating cells. This article reviews recent progress in elucidating the genetic programs and dynamics of NSC and OPC proliferation, differentiation, and apoptosis, including the response to demyelination. Emerging knowledge of the molecules that may be involved in such responses may help in the design of future stem cell-based treatment of demyelinating diseases such as multiple sclerosis.

Entities:  

Mesh:

Year:  2003        PMID: 12923300     DOI: 10.1152/physiolgenomics.00021.2002

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  19 in total

1.  Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotic stimuli.

Authors:  Jaime Imitola; Manuel Comabella; Anil K Chandraker; Fernando Dangond; Mohamed H Sayegh; Evan Y Snyder; Samia J Khoury
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

2.  Conference report--stem cells and neurologic repair: highlights from the annual meeting of the American Society of Neuroscience; November 8-12, 2003; New Orleans, Louisiana.

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-01-13

Review 3.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

4.  CXCR4 signaling regulates remyelination by endogenous oligodendrocyte progenitor cells in a viral model of demyelination.

Authors:  Kevin S Carbajal; Juan L Miranda; Michelle R Tsukamoto; Thomas E Lane
Journal:  Glia       Date:  2011-08-09       Impact factor: 7.452

Review 5.  Nitric oxide and multiple sclerosis.

Authors:  Juan Manuel Encinas; Louis Manganas; Grigori Enikolopov
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

Review 6.  Prospects for neural stem cell-based therapies for neurological diseases.

Authors:  Jaime Imitola
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

7.  Regulation of neural stem cell in the human SVZ by trophic and morphogenic factors.

Authors:  Lucia E Alvarez-Palazuelos; Martha S Robles-Cervantes; Gabriel Castillo-Velazquez; Mario Rivas-Souza; Jorge Guzman-Muniz; Norma Moy-Lopez; Rocio E Gonzalez-Castaneda; Sonia Luquin; Oscar Gonzalez-Perez
Journal:  Curr Signal Transduct Ther       Date:  2011-09-01

8.  HIV Non-Nucleoside Reverse Transcriptase Inhibitor Efavirenz Reduces Neural Stem Cell Proliferation in Vitro and in Vivo.

Authors:  Jingji Jin; Bethany Grimmig; James Izzo; Lecia A M Brown; Charles Hudson; Adam J Smith; Jun Tan; Paula C Bickford; Brian Giunta
Journal:  Cell Transplant       Date:  2016-11       Impact factor: 4.064

9.  Paradoxical dysregulation of the neural stem cell pathway sonic hedgehog-Gli1 in autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Yue Wang; Jaime Imitola; Stine Rasmussen; Kevin C O'Connor; Samia J Khoury
Journal:  Ann Neurol       Date:  2008-10       Impact factor: 10.422

Review 10.  CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.

Authors:  A Arévalo-Martín; D García-Ovejero; O Gómez; A Rubio-Araiz; B Navarro-Galve; C Guaza; E Molina-Holgado; F Molina-Holgado
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.